U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811856) titled 'Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome' on Sept. 04.

Brief Summary: Polycystic ovary syndrome (PCOS) is a common condition associated with metabolic abnormalities, including insulin resistance, impaired glucose regulation, and abnormal lipid levels. Metformin is commonly used to improve metabolic outcomes in women with PCOS, while lifestyle modification and behavioral education are important components of PCOS management. This study evaluates whether metformin, alone or combined with a theory-based behavioral educational program, is associated with changes in metabolic, vitamin B12, ...